Alto Neuroscience
Clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform. Learn more
Launch date
Employees
Market cap
CAD501m
Enterprise valuation
CAD251m (Public information from Sep 2024)
Share price
$13.69 ANRO
Los Altos California (HQ)
Authorizing premium user...